RXRX
Recursion Pharmaceuticals, Inc.NASDAQHealthcare$3.15+1.29%ClosedMarket Cap: $1.41B
As of 2026-04-07
Analyst Consensus
Consensus
Hold
Target (Consensus)
$11.00
Target (Median)
$11.00
Target Range
$11.00 - $11.00
Upside from current price: 249.2%
Rating Distribution
2 Strong Buy1 Buy5 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-02-26 | Needham | maintain | Buy | Buy |
| 2026-02-26 | B of A Securities | maintain | Neutral | Neutral |
| 2025-12-17 | JP Morgan | upgrade | Overweight | Neutral |
| 2025-09-11 | Needham | maintain | Buy | Buy |
| 2025-07-08 | Needham | maintain | Buy | Buy |
| 2025-06-16 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| 2025-05-06 | Needham | maintain | Buy | Buy |
| 2025-04-10 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Thu Dec 31 | $-0.99 | $82.1M | 5 |
| Fri Dec 31 | $-0.87 | $149.8M | 6 |
| Sun Dec 31 | $-0.45 | $441.1M | 3 |
| Mon Dec 31 | $-0.94 | $247.5M | 4 |